Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2020-12-13
2021-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Oral and nasal swabs will be taken from 150 patients (50 with mild form and 50 with severe form of COVID-19 with or without mechanical ventilation, 50 healthy controls).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of the Oral Microbiome & Mucosal Immunity in COVID-19 Disease
NCT05212766
Antimicrobial Agent for Reducing Bacteria in Aerosols and Oral Cavity
NCT02319668
A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 Patients
NCT04950803
The Influence of Endurance Sports Activity on the Oral Microbiota of Young Adults.
NCT05765422
An Efficacy Study of Stain Control of a 67% Sodium Bicarbonate Containing Toothpaste on Chlorhexidine Tooth Staining
NCT01962493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Controls tested PCR (-) for COVID-19
Swab
PCR test for SARS-CoV2, oral and nasal swab
Tested PCR (+) for COVID-19, Mild - not admitted to the hospital
Swab
PCR test for SARS-CoV2, oral and nasal swab
Tested PCR (+) for COVID-19, Severe - admitted to ICU (Intensive Care Unit)
Swab
PCR test for SARS-CoV2, oral and nasal swab
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Swab
PCR test for SARS-CoV2, oral and nasal swab
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects have to be tested (PCR) positive or negative for SARS-CoV2 infection
3. Must be able to provide oral and nasal swabbing within 48 hours of polymerise chain reaction (PCR) test results
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DermBiont, Inc.
INDUSTRY
University College London Hospitals
OTHER
The Whittington Hospital NHS Trust
OTHER_GOV
Eastman Dental Insitute and Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof Francesco D'Aiuto
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University College Hospital (UCH), UCL Eastman Dental Institute
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
283766
Identifier Type: OTHER
Identifier Source: secondary_id
EDGE 132868
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.